- Clinical Essentials from HIV Med
- 1 comment
High HCV-1 clearance rates, even in cirrhosis.
There may be increased susceptibility at later age.
CPR international consensus recommendations | A call for newborn CHD screening | ACC decision pathway for bleeding management with anticoagulants.
Adding pazopanib to paclitaxel boosts toxicity, but not survival.
WSG-ADAPT-TN randomized trial reveals higher pCR rate and fewer adverse events.
One exception is urgent surgery.
Hemophilia-related mortality less likely related to cardiac complications and cancer.
Rituximab had the greatest impact in decreasing fatigue at 1 mo.
Evidence for 5-year effectiveness and safety.
Data from over 141K individuals in 2 prospective cohorts shows no association.
An observational cohort study of a care model used in the Netherlands.
Carboplatin is the preferred treatment, but thromboembolism risk was understudied.
Studies show mixed results in these patients.
It’s as effective as face-to-face training, and both are better than usual care.
The drugs performed similarly in a Danish registry study.